Document is current
Any future updates will be listed below
-
Authors
Carroué, Marine
Happernegg, Eloise
Perrot, Flavie
Boucau, Marie-Christine
Dehouck, Lucie
Sevin, Emmanuel
Arcicasa, Mélanie
Balsamelli, Joanne
Shimizu, Fumitaka
Kanda, Takashi
Carcaboso, Angel M.
Toillon, Robert-Alain
Culot, Maxime
Meignan, Samuel
Gosselet, Fabien
Mysiorek, Caroline
-
Funding
Funding for this research was provided by:
Région Hauts-de-France
Université d'Artois
Association Cassandra Contre La Leucémie
Fondation pour la Recherche Médicale
CPER MOSOPS
- License Information
-
More Information
Article History
Received: 16 September 2025
Accepted: 13 February 2026
First Online: 24 February 2026
Declarations
:
: Human pericytes are from the cell line named hBPs and has been provided by Professor Takashi Kanda’s group from Yamagushi university (Japan). The study protocol was approved by local ethic committee and conducted in accordance with the declaration of Helsinki, as amended in Somerset West in 1996 [ ]. The collection and use of CD-34 + stem cells derived from cord blood has been approved since 2011 by the French ministry (CODECOH 2011 − 1321). These cells were harvested thanks to an agreement established between the hospital of Béthune and university of Artois. Informed consents were obtained from the families before starting the study. Patient-derived cells were obtained under an Institutional Review Board-approved protocol and with written informed consent (M-1608-C) at Hospital Sant Joan de Deu Barcelona, Spain.
: The authors declare no competing interests.
: Not applicable.
